Event Cardio Group Acquires National Cardiac Monitoring
Center





 


July 13, 2016


NEW YORK, NY--(Marketwired - July 13, 2016) - Event
Cardio Group, Inc. (ECGI) closed its acquisition of National Cardiac Monitoring Center ("NCMC")
in Glenelg, Maryland in a Stock Purchase Agreement worth approximately $5 million in a combination of cash and ECGI common stock.


NCMC has been providing cardiac diagnostic services
since 1986. It provides a range of cardiac monitoring modalities including Mobile Cardiac Telemetry (MCT), wireless and trans-telephonic
cardiac event monitoring (CEM), 24/48-hour digital Holter monitoring with data transmission to NCMC, 24-hour ABP monitoring, full
time and off-hours monitoring, and triage. The facility can receive any number of patient calls simultaneously, with patients
receiving immediate, one-on-one service every time they call. NCMC's facilities will be used to continuously receive and interpret
the data collected by NowCardio monitors once they are in commercial use in the United States.


NCMC, a FDA-registered independent diagnostic testing
facility, with 2016 projected sales of $2,500,000 and approximately 900 customers, provides electrocardiography support services
designed specifically for physicians, hospitals, scanning services and home health care agencies, including a 24-hour/day ECG
monitoring center.


John Bentivoglio, CEO and President of Event Cardio
Group, stated, "The acquisition of NCMC comes at a pivotal time in our company's development as we recently received clearance
from Health Canada to sell our NowCardioTM heart monitoring system, our noninvasive continuous heart monitoring device, as
a Class 2 Medical Device in Canada. We also anticipate submitting our 510(k) application with the United States Food and Drug
Administration (FDA) in late July. We welcome NCMC to Event Cardio Group and look forward to servicing NCMC's existing customer
base and integrating our operations in a seamless transition."


Effective immediately, Richard Owsik, formerly president
and CEO of NCMC, will become a consultant to Event Cardio Group and Joseph Hashim, formerly Vice President of NCMC, will become
VP Sales and Marketing. Mr. Hashim's responsibilities will include helping prepare NowCardio for commercial launch. EventCardio
expects to retain all NCMC staff, consisting of 10 staff members and 19 sales representatives in 15 states. The company plans
on expanding its sales force to 25 states by the end of 2016 and all 50 states by the end of 2017. NCMC will continue to operate
under the National Cardiac Monitoring Center name and will be the U.S. headquarters for NowCardio and Event Cardio Group.


About Event Cardio Group, Inc.


Event Cardio Group, Inc. is a developer of medical
diagnostic equipment that focuses on the detection, and preventive treatment, of high-risk diseases. The Company's core product
is NowCardioTM, an advanced Ambulatory Arrhythmia Monitoring System monitor which offers the combined functionality of holter
monitoring, event recording and mobile cardiac telemetry simultaneously within in a single device. NowCardioTM has been cleared
for commercial use in Canada. For more information on the company please visit www.eventcardiogroup.com.


Forward Looking Statements


Statements in this release may be regarded, in certain
instances, as "forward-looking statements" pursuant to certain sections of the Securities Act 1933 and the Securities
Exchange Act 1934, respectively. "Forward-looking statements" are based on expectations, estimates and projections at
the time the statements are made, and involve risks and uncertainties, which could cause actual results or events to differ materially
from those currently anticipated, including, but not limited to delays, difficulties, changed strategies, or unanticipated factors
or circumstances affecting Event Cardio Group, Inc. and its business. There can be no assurance that such forward-looking statements
will ever prove to be accurate and readers should not place undue reliance on any such forward-looking statements contained herein.
Event Cardio Group, Inc. will not republish revised forward-looking statements to reflect events or circumstances after the date
hereof to reflect the occurrence of unanticipated events.